down arrow

Vaishali Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE972X01022
  • NSEID: VAISHALI
  • BSEID:
INR
8.42
-0.22 (-2.55%)
BSENSE

Dec 05

BSE+NSE Vol: 94178

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Net Sales
33.45
Other Operating Income
0.00
Total Operating income
33.45
Raw Material Cost
0.00
Purchase of Finished goods
28.00
(Increase) / Decrease In Stocks
1.69
Employee Cost
0.63
Power Cost
0.00
Manufacturing Expenses
0.01
Selling and Distribution Expenses
0.00
Other Expenses
1.73
Total Expenditure (Excl Depreciation)
32.06
Operating Profit (PBDIT) excl Other Income
1.39
Other Income
0.84
Operating Profit (PBDIT)
2.23
Interest
0.40
Exceptional Items
0.00
Gross Profit (PBDT)
1.83
Depreciation
0.17
Profit Before Tax
1.66
Tax
0.47
Provisions and contingencies
0.00
Profit After Tax
1.18
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
1.18
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
1.19
Equity Capital
13.05
Face Value
1.0
Reserves
0.00
Earnings per share (EPS)
0.09
Diluted Earnings per share
0.09
Operating Profit Margin (Excl OI)
4.16%
Gross Profit Margin
5.47%
PAT Margin
3.53%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 60.89% vs 65.39% in Sep 2024

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -40.10% vs 15.88% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -42.56% vs -9.02% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 5.26% vs -19.15% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Vaishali Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
33.45
0
33.45
Other Operating Income
0.00
0.00
0.00
Total Operating income
33.45
0
33.45
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
28.00
0
28.00
(Increase) / Decrease In Stocks
1.69
0
1.69
Employee Cost
0.63
0
0.63
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
1.73
0.00
1.73
Total Expenditure (Excl Depreciation)
32.06
0
32.06
Operating Profit (PBDIT) excl Other Income
1.39
0.00
1.39
Other Income
0.84
0
0.84
Operating Profit (PBDIT)
2.23
0
2.23
Interest
0.40
0
0.40
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1.83
0
1.83
Depreciation
0.17
0
0.17
Profit Before Tax
1.66
0
1.66
Tax
0.47
0
0.47
Provisions and contingencies
0.00
0
0.00
Profit After Tax
1.18
0
1.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
1.18
0
1.18
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1.19
0
1.19
Equity Capital
13.05
0
13.05
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
4.16%
0%
0.00
4.16%
Gross Profit Margin
5.47%
0%
0.00
5.47%
PAT Margin
3.53%
0%
0.00
3.53%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 33.45 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 40.84% vs -26.36% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 60.89% vs 65.39% in Sep 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 1.18 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.81% vs 129.84% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -40.10% vs 15.88% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.39 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.46% vs 122.68% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -42.56% vs -9.02% in Sep 2024

Quarterly - Interest
Interest 0.40 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.21% vs -25.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.26% vs -19.15% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.16%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."